Cite

HARVARD Citation

    Bixby, D. et al. (2019). Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: results of a phase Ib trial. British journal of haematology. pp. 595-598. [Online]. 
  
Back to record